These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15205705)

  • 1. [Preparation and properties of 5-fluorouracil-loaded chitosan microspheres for the intranasal administration].
    Zheng AP; Yu SY; Zhao Y; Wu FL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):300-4. PubMed ID: 15205705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and Properties of 5-Fluorouracil-Loaded Chitosan Microspheres for the Intranasal Administration.
    Li W; Ba H; Huang P; Zheng A; Yang X
    Drug Res (Stuttg); 2018 Dec; 68(12):673-679. PubMed ID: 29966151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration.
    Sankar C; Mishra B
    Acta Pharm; 2003 Jun; 53(2):101-10. PubMed ID: 14764244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-fluorouracil loaded chitosan microspheres for chemoembolization.
    Denkbaş EB; Seyyal M; Pişkin E
    J Microencapsul; 1999; 16(6):741-9. PubMed ID: 10575626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability enhancement of verapamil HCl via intranasal chitosan microspheres.
    Abdel Mouez M; Zaki NM; Mansour S; Geneidi AS
    Eur J Pharm Sci; 2014 Jan; 51():59-66. PubMed ID: 23999035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan.
    Lim ST; Martin GP; Berry DJ; Brown MB
    J Control Release; 2000 May; 66(2-3):281-92. PubMed ID: 10742587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
    Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
    J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies.
    Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P
    Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive chitosan microspheres of carvedilol for nasal administration.
    Patil S; Babbar A; Mathur R; Mishra A; Sawant K
    J Drug Target; 2010 May; 18(4):321-31. PubMed ID: 20199172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of spray-dried mucoadhesive microspheres of ketorolac for nasal administration.
    Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
    Curr Drug Deliv; 2012 Mar; 9(2):205-18. PubMed ID: 22023210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac.
    Nagda CD; Chotai NP; Nagda DC; Patel SB; Patel UL
    Pharmazie; 2011 Apr; 66(4):249-57. PubMed ID: 21612151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of chitosan microspheres containing doxifluridine.
    Yoshino T; Machida Y; Onishi H; Nagai T
    Drug Dev Ind Pharm; 2003 Apr; 29(4):417-27. PubMed ID: 12737535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and evaluation of ranitidine hydrochloride-loaded mucoadhesive microspheres.
    Dhankar V; Garg G; Dhamija K; Awasthi R
    Polim Med; 2014; 44(2):75-81. PubMed ID: 24967779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of 5-Fluorouracil loaded chitosan microspheres by a two-step solidification method.
    Sun Y; Gu L; Gao Y; Gao F
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):891-5. PubMed ID: 20606332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation.
    Sankar C; Rani M; Srivastava AK; Mishra B
    Pharmazie; 2001 Mar; 56(3):223-6. PubMed ID: 11265588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of magnesium stearate on chitosan microspheres prepared by an emulsification-coacervation technique.
    Lim LY; Wan LS
    J Microencapsul; 1998; 15(3):319-33. PubMed ID: 9608395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chitosan molecular weight on the characteristics of spray-dried methotrexate-loaded chitosan microspheres for nasal administration.
    Sun Y; Cui F; Shi K; Wang J; Niu M; Ma R
    Drug Dev Ind Pharm; 2009 Mar; 35(3):379-86. PubMed ID: 18951272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-stage optimization process for formulation of chitosan microspheres.
    Dubey RR; Parikh RH
    AAPS PharmSciTech; 2004 Feb; 5(1):E5. PubMed ID: 15198526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spray-dried carbamazepine-loaded chitosan and HPMC microspheres: preparation and characterisation.
    Filipović-Grcić J; Perissutti B; Moneghini M; Voinovich D; Martinac A; Jalsenjak I
    J Pharm Pharmacol; 2003 Jul; 55(7):921-31. PubMed ID: 12906749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.